Developer of robotic systems designed to bring the benefits of minimal access surgery to the patients.
Developer of robotic systems designed to bring the benefits of minimal access surgery to the patients.
Surgical Devices📍 Cambridge, United KingdomFounded 2014
Current Valuation
$3.0B
as of 2025-Q2
UNICORN
QL Price
$3.0B
0% vs last round
QuantLogix's current estimate for CMR Surgical, published 2026-09-27 — in line with the last disclosed round of $3.0B (2025-Q2).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$3.0B
2025-Q2
weight 0.42
How this price has held up
No round has priced for CMR Surgical since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, CMR Surgical, 2026-09-27 (d7ebcbc39ec74ab0).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is CMR Surgical going public?
No. CMR Surgical is private and has not filed to go public. There is no S-1 on file.
What is CMR Surgical's valuation in 2026?
CMR Surgical is valued at $3.0B as of 2025-Q2, set by its Later Stage VC ($200M, Apr 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has CMR Surgical filed an S-1?
No public S-1 is on file for CMR Surgical.
How much has CMR Surgical raised?
CMR Surgical has raised $1.5B in total, most recently a Later Stage VC of $200M in Apr 2025.
Is CMR Surgical publicly traded — can you buy CMR Surgical stock?
No. CMR Surgical is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for CMR Surgical on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2014
HQ
Cambridge, United Kingdom
Employees
642
Total Raised
$1.5B
Last Round
Later Stage VC — $200M (Apr 2025)
IPO Status
private
Fundraising Status
Later Stage VC · $200M · 1y 5mo ago
privateTotal raised $1.5B
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Later Stage VC
$200M
Apr 2025
—
$3.0B
Talent Signal
Hiring trend
▶ Hiring steady
0% vs 2026-08
Open roles
4
via careers page
Product-build share
75%
engineering, research, product, design
Trajectory
steady
heavy product build — 75% of open roles are product-building functions (engineering/research/product) — 2 of 4 open roles are medical.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Surgical team looking at clinical dataFreedom to Access By Design - Versius PlusClinical and operational monitoringSkip to content
Counted from CMR Surgical's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
RoboticsHealth CareMedical Device
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q2. Refreshed quarterly.